Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (the TRANSFORM-DME Trial) a Multicenter Observational Study
CLINICAL OPHTHALMOLOGY(2024)
Key words
diabetic macular edema,anti VEGF,aflibercept,biosimilar ranibizumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined